You are here: Industry Insights > Zydus

News List

Zydus to present PBC and NASH clinical trial data of Saroglitazar Mg at AASLD event expresspharma
November 04, 2020
Zydus announced that a Late-Breaker Oral Presentation and two Poster Presentations on Saroglitazar Mg has been accepted for presentation at The Liver Meeting 2020, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) ...
Zydus starts human trials of ZyCoV-D, its COVID-19 vaccine expresspharma
July 16, 2020
The company will be enrolling over 1000 subjects across multiple clinical study sites in India for Adaptive Phase I/ II clinical trials.
Zydus gets nod from COFEPRIS, Mexico to study Desidustat for COVID-19 management expresspharma
July 07, 2020
As a part of the study, 100 mg tablets of Desidustat will be administered for a period of 14 days along with recommended standard care during the trial.
Zydus gets tentative USFDA approval for empagliflozin and metformin hydrochloride tablets expresspharma
May 04, 2020
It will be manufactured at the group’s formulations manufacturing facility at SEZ in Ahmedabad.
Zydus receives tentative nod from USFDA for Empagliflozin Tablets expresspharma
April 13, 2020
The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.
Zydus, XOMA Enter IO Agreement contractpharma
March 10, 2020
To advance an IL-2-based immuno-oncology drug candidate that combines Zydus’ IL-2 with XOMA’s novel anti-IL-2 monoclonal antibody.
Zydus’ saroglitazar becomes first NASH drug approved globally pharmaceutical-technology
March 09, 2020
The Drug Controller General of India has approved Zydus’ saroglitazar for non-cirrhotic non-alcoholic steatohepatitis (NASH).
Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules biospectrumasia
June 18, 2019
It is used along with diet and exercise to help lower levels of a certain blood fat (triglyceride)
Zydus set to market generic anti-diabetic drug biospectrumasia
March 15, 2019
Zydus receives tentative approval from the USFDA for Sitagliptin and Metformin Hydrochloride Extended-Release tablets
Zydus Cadila gets US FDA nod for erectile dysfunction drug financialexpress
June 29, 2018
Drug firm Zydus Cadila has received approval from the US health regulator to market Tadalafil tablets, used to erectile dysfunction, in the American market.

Previous page 1 2 3 4 5 Next page